Incidence and Clinical Outcomes of Clostridium difficile Infection after Treatment with Tuberculosis Medication
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: To determine the incidence and clinical characteristics of tuberculosis (TB) medication-associated Clostridium difficile infection. Methods: This multicenter study included patients from eight tertiary hospitals enrolled from 2008 to 2013. A retrospective analysis was conducted to identify the clinical features of C. difficile infection in patients who received TB medication. Results: C. difficile infection developed in 54 of the 19,080 patients prescribed TB medication, representing a total incidence of infection of 2.83 cases per 1,000 adults. Fifty-one of the 54 patients (94.4%) were treated with rifampin. The patients were usually treated with oral metronidazole, which produced improvement in 47 of the 54 patients (87%). Twenty-three patients clinically improved with continuous rifampin therapy for C. difficile infection. There were no significant differences in improvement between patients treated continuously (n=21) and patients in whom treatment was discontinued (n=26). Conclusions: The incidence of C. difficile infection after TB medication was not low considering the relatively low TB medication dosage compared to other antibiotics. It may not be always necessary to discontinue TB medication. Instead, decisions concerning discontinuation of TB medication should be based on TB status.
Abstract
Background/Aims: To determine the incidence and clinical characteristics of tuberculosis (TB) medication-associated Clostridium difficile infection. Methods: This multicenter study included patients from eight tertiary hospitals enrolled from 2008 to 2013. A retrospective analysis was conducted to identify the clinical features of C. difficile infection in patients who received TB medication. Results: C. difficile infection developed in 54 of the 19,080 patients prescribed TB medication, representing a total incidence of infection of 2.83 cases per 1,000 adults. Fifty-one of the 54 patients (94.4%) were treated with rifampin. The patients were usually treated with oral metronidazole, which produced improvement in 47 of the 54 patients (87%). Twenty-three patients clinically improved with continuous rifampin therapy for C. difficile infection. There were no significant differences in improvement between patients treated continuously (n=21) and patients in whom treatment was discontinued (n=26). Conclusions: The incidence of C. difficile infection after TB medication was not low considering the relatively low TB medication dosage compared to other antibiotics. It may not be always necessary to discontinue TB medication. Instead, decisions concerning discontinuation of TB medication should be based on TB status.
참고문헌 (23)
- Khanna S, "The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings", Expert Rev Gastroenterol Hepatol, 4, pp.409~416 (2010)
- 권태근, "A Case of Toxic Megacolon Caused by Clostridium difficile Infection and Treated with Fecal Microbiota Transplantation", Gut and Liver, 9(2), pp.247~250 (2015), 거트앤리버 발행위원회
- Karas JA, "A review of mortality due to Clostridium difficile infection", J Infect, 61, pp.1~8 (2010)
- Kristin E. Burke, "Clostridium difficile Infection: A Worldwide Disease", Gut and Liver, 8(1), pp.1~6 (2014), 거트앤리버 발행위원회
- 서검석, "Clostridium difficile Infection: What’s New?", Intestinal research, 11(1), pp.1~13 (2013), 대한장연구학회
- Cohen SH, "Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)", Infect Control Hosp Epidemiol, 31, pp.431~455 (2010)
- Kim YS, "Incidence and clinical features of Clostridium difficile infection in Korea: a nationwide study", Epidemiol Infect, 141, pp.189~194 (2013)
- Klaui H, "Pseudomembranous colitis due to rifampicin", Lancet, 2, pp.1294~ (1981)
- "WHO statistical information system" (2014)[URL]
- Kyne L, "Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A", N Engl J Med, 342, pp.390~397 (2000)
- Gravel D, "Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study", Clin Infect Dis, 48, pp.568~576 (2009)
- Bauer MP, "Clostridium difficile infection in Europe: a hospital-based survey", Lancet, 377, pp.63~73 (2011)
- Kelly CP, "Clostridium difficile colitis", N Engl J Med, 330, pp.257~262 (1994)
- Park JY, "A case of pseudomembranous colitis associated with rifampin", Korean J Intern Med, 19, pp.261~265 (2004)
- Boriello SP, "Rifampicin-associated pseudomembranous colitis", Br Med J, 281, pp.1180~1181 (1980)
- Sun Young Yim, "Rifampin-induced Pseudomembranous Colitis with Rectosigmoid Sparing", Clinical Endoscopy, 44(2), pp.137~139 (2011), 대한소화기내시경학회
- Jung SW, "Clinical aspects of rifampicinassociated pseudomembranous colitis", J Clin Gastroenterol, 41, pp.38~40 (2007)
- Nakajima A, "Rifampicin-associated pseudomembranous colitis", J Gastroenterol, 35, pp.299~303 (2000)
- Fournier G, "Pseudomembranous colitis probably due to rifampicin", Lancet, 1, pp.101~ (1980)
- Chen TC, "Rifampin-associated pseudomembranous colitis", Am J Med Sci, 338, pp.156~158 (2009)
- 도영석, "Long-Term Clinical Outcome of Clostridium difficile Infection in Hospitalized Patients: A Single Center Study", Intestinal research, 12(4), pp.299~305 (2014), 대한장연구학회
- Schroeder MS, "Clostridium difficile: associated diarrhea", Am Fam Physician, 71, pp.921~928 (2005)
- 우명렬, "항결핵제를 유지하면서 치료한 항결핵제 유발 위막성 대장염 치험 1예", Clinical Endoscopy, 38(1), pp.47~51 (2009), 대한소화기내시경학회